Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jan;8(1):45-7.

Risk of lymphoma in patients with inflammatory bowel disease

Affiliations

Risk of lymphoma in patients with inflammatory bowel disease

James D Lewis. Gastroenterol Hepatol (N Y). 2012 Jan.
No abstract available

PubMed Disclaimer

Similar articles

Cited by

References

    1. Kandiel A, Fraser AG, Korelitz BI, Brensinger C, Lewis JD. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut. 2005;54:1121–1125. - PMC - PubMed
    1. Bewtra M, Lewis JD. Safety profile of IBD: lymphoma risks. Gastroenterol Clin North Am. 2009;38:669–689. - PubMed
    1. Beaugerie L, Brousse N, Bouvier AM, et al. CESAME Study Group. Lympho-proliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet. 2009;374:1617–1625. - PubMed
    1. Herrinton LJ, Liu L, Weng X, Lewis JD, Hutfless S, Allison JE. Role of thiopurine and anti-TNF therapy in lymphoma in inflammatory bowel disease. Am J Gastroenterol. 2011;106:2146–2153. - PubMed
    1. Van Assche G, Lewis JD, Lichtenstein GR, et al. The London position statement of the World Congress of Gastroenterology on biological therapy for IBD with the European Crohn舗s and Colitis Organisation: safety. Am J Gastroenterol. 2011;106:1594–1602. quiz 1593, 1603. - PubMed

LinkOut - more resources